Literature DB >> 23387879

Inducibility of atrial fibrillation and flutter following pulmonary vein ablation.

Peter Leong-Sit1, Melissa Robinson, Erica S Zado, David J Callans, Fermin Garcia, David Lin, Sanjay Dixit, Rupa Bala, Michael P Riley, Mathew D Hutchinson, Joshua Cooper, Edward P Gerstenfeld, Francis E Marchlinski.   

Abstract

INTRODUCTION: Prior reports demonstrate prognostic value in noninducibility of atrial arrhythmias after atrial fibrillation (AF) ablation and suggest their utility in guiding additional ablation lesion sets. The type and mechanism of induced atrial arrhythmias, their relationship to the underlying atrial substrate, and prognostic significance of induced organized atrial arrhythmias are unknown. METHODS AND
RESULTS: One hundred forty-four patients (30 women; median age 60 years; 54% with paroxysmal AF) undergoing AF ablation (circumferential pulmonary vein isolation and focal ablation of nonvein triggers on isoproterenol) were evaluated prospectively. All underwent a standardized postablation induction protocol from the coronary sinus and right atrium: 15 beat burst pacing at 250 milliseconds and decrementing to 180 milliseconds. Sustained rhythms were defined as greater than 2 minutes Of 144 patients, 55 patients (38.2%) did not have sustained inducible arrhythmias. Fifty-two (36.1%) had inducible AF and 37 (25.7%) had inducible organized arrhythmias. A logistic regression analysis showed that age (OR 2.10 per decade; P = 0.003) and hypertension (OR 4.15; P = 0.009) were predictive of inducibility. However, inducibility of either AF or organized arrhythmias was not prognostic of clinical recurrence at 1 year postablation (P = 0.65). Furthermore, inducibility of organized arrhythmias did not predict clinical recurrence of an organized arrhythmia. Only LA size (OR 2.18; 95% CI 1.02-4.67; P = 0.04) and persistent AF (OR 2.43; 95% CI 1.09-5.40; P = 0.03) predicted atrial arrhythmia recurrence.
CONCLUSIONS: Multisite atrial burst pacing post-AF ablation induced organized rhythms in 25.7% and AF in 36.1% of patients after AF ablation. Hypertension and age predict inducibility of arrhythmias, but inducibility did not predict clinical recurrence in follow-up. Distinguishing organized atrial arrhythmias from AF did not yield any further prognostic information. The utility of aggressive stimulation protocols after AF ablation for prognosis and to guide therapy appears limited.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23387879     DOI: 10.1111/jce.12088

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  14 in total

Review 1.  Non-Inducibility Or Termination As Endpoints Of Atrial Fibrillation Ablation: What Is The Role?

Authors:  Matthew Baker; Prabhat Kumar; James P Hummel; Anil K Gehi
Journal:  J Atr Fibrillation       Date:  2014-10-31

2.  Efficacy of atrial substrate modification based on dominant frequency of paroxysmal atrial fibrillation.

Authors:  Koji Kumagai; Kentaro Minami; Daisuke Kutsuzawa; Shigeru Oshima
Journal:  J Arrhythm       Date:  2016-03-14

3.  Arrhythmia Termination Versus Elimination of Dormant Pulmonary Vein Conduction as a Procedural End Point of Catheter Ablation for Paroxysmal Atrial Fibrillation: A Prospective Randomized Trial.

Authors:  Cathrin Theis; Torsten Konrad; Hanke Mollnau; Sebastian Sonnenschein; Denise Kämpfner; Maik Potstawa; Blanca Quesada Ocete; Karsten Bock; Ewald Himmrich; Thomas Münzel; Thomas Rostock
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-08-21

4.  Anatomical dilatation of the superior vena cava associated with an arrhythmogenic response induced by SVC scan pacing after atrial fibrillation ablation.

Authors:  Hiroshi Imada; Koji Fukuzawa; Kunihiko Kiuchi; Akinori Matsumoto; Hiroki Konishi; Hirotoshi Ichibori; Kiyohiro Hyogo; Jun Kurose; Shumpei Mori; Tomofumi Takaya; Tatsuya Nishii; Kiyosumi Kagawa; Akihiro Yoshida; Hirata Ken-Ichi
Journal:  J Arrhythm       Date:  2016-10-27

5.  Evaluation of the characteristics of rotational activation at high-dominant frequency and complex fractionated atrial electrogram sites during atrial fibrillation.

Authors:  Koji Kumagai; Kentaro Minami; Daisuke Kutsuzawa; Shigeru Oshima
Journal:  J Arrhythm       Date:  2016-07-13

6.  Predictive value of noninducibility after catheter ablation for paroxysmal and persistent atrial fibrillation.

Authors:  Shinichi Tachibana; Akira Mizukami; Shunsuke Kuroda; Tatsuya Hayashi; Akihiko Matsumura; Masahiko Goya; Tetsuo Sasano
Journal:  J Arrhythm       Date:  2020-03-02

7.  Impact of electrophysiological and pharmacological noninducibility following pulmonary vein isolation in patients with paroxysmal and persistent atrial fibrillation.

Authors:  Takayuki Otsuka; Koichi Sagara; Takuto Arita; Naoharu Yagi; Shinya Suzuki; Takanori Ikeda; Takeshi Yamashita
Journal:  J Arrhythm       Date:  2018-09-10

8.  Prognostic Value of Atrial Fibrillation Inducibility in Patients Without History of Clinical Atrial Fibrillation.

Authors:  Jonathan Marquardt; Kira Marquardt; Christian Scheckenbach; Wenzhong Zhang; Fabian Stimpfle; Martin Duckheim; Carole Maleck; Peter Seizer; Meinrad Gawaz; Jürgen Schreieck; Michael Gramlich
Journal:  J Atr Fibrillation       Date:  2018-06-30

9.  Incidence, electrophysiological characteristics, and long-term follow-up of perimitral atrial flutter in patients with previously confirmed mitral isthmus block.

Authors:  Panagiotis Ioannidis; Evangelia Christoforatou; Theodoros Zografos; Panagiotis Charalambopoulos; Konstantinos Kouvelas; Georgios Christoulas; Periklis Syros; Georgios Tsitsinakis; Theodora Kappou; Andreas Tsoumeleas; Sotirios Floros; Dimitrios Tagoulis; Ioannis Ntarladimas; Ioannis Tagoulis; Dimitrios Avzotis; Antonis S Manolis; Charalambos Vassilopoulos
Journal:  J Arrhythm       Date:  2021-05-12

10.  Ablation as targeted perturbation to rewire communication network of persistent atrial fibrillation.

Authors:  Susumu Tao; Samuel F Way; Joshua Garland; Jonathan Chrispin; Luisa A Ciuffo; Muhammad A Balouch; Saman Nazarian; David D Spragg; Joseph E Marine; Ronald D Berger; Hugh Calkins; Hiroshi Ashikaga
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.